Back to Rare Disease
This trial is complete. It is no longer accepting participants. Results may be available on ClinicalTrials.gov.

NCT04844697

NCT04844697
Completed Not Applicable

Who may be able to join

Who might be able to join this trial:

  • You have been diagnosed with Multiple Osteochondromas (a condition where multiple bony growths form near the joints), either through medical examination or genetic testing
  • You have been diagnosed with Ollier disease or Maffucci syndrome (conditions involving abnormal bone and/or tissue growths), either through medical examination or genetic testing
  • You have been diagnosed with Osteogenesis Imperfecta (a condition sometimes called "brittle bone disease"), either through medical examination or genetic testing
  • You are willing to give your consent to take part in the study

Who may not be able to join:

  • You do not have a diagnosis of any of the conditions listed above (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

Trial details

Status
Completed
Phase
Not Applicable
Sponsor
Istituto Ortopedico Rizzoli
Registry
clinicaltrials_gov
Start date
12 May 2021
Est. completion
31 December 2022

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Resilience; Resilience; Resilience

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

View original record on ClinicalTrials.gov